智能手机自助失眠认知行为疗法治疗抑郁症:平行组随机对照试验方案
本研究为一项在285名香港华人中开展的等待组对照、平行组随机对照试验方案,评估智能手机应用proACT-S自助失眠认知行为疗法对重性抑郁与失眠共病患者的疗效。主要结局为睡眠质量、失眠严重程度和抑郁严重程度的变化,次要结局包括焦虑、主观健康、治疗期望和可接受性。研究已完成招募,将按意向性治疗原则用多层线性混合模型分析。
要点
- 方案评估proACT-S自助CBT-I对重性抑郁共病失眠患者的疗效
- 采用等待组对照、1:1随机、分配隐藏的平行组设计,样本量285
- 主要结局为睡眠质量、失眠严重度和抑郁严重度变化
核心结论
- 研究预期proACT-S是一种有效的简短、聚焦睡眠的自助治疗,用于重性抑郁与失眠患者。
- 若证实有效,因其自助性质,proACT-S或可作为社区早期干预,减轻香港公共医疗系统负担。
研究设计与样本
- 两臂平行随机对照试验,目标样本为285名年龄大于17岁、非自杀性、香港华人、患有重性抑郁和失眠者。
- 参与者先完成在线快速筛查,随后接受电话诊断访谈,符合纳入标准者按1:1随机分配至立即CBT-I组或等待组。
- CBT-I含六个每周模块,通过智能手机应用proACT-S提供,该应用已进行试点测试并改进用户体验。
- 使用在线随机算法进行随机化以确保分配隐藏,招募已完成。
- 评估在基线、干预后和6周随访时进行,重要不良事件若有则记录。
关键数值与推荐
- 主要结局为睡眠质量、失眠严重程度和抑郁严重程度在各测量点的变化。
- 次要结局包括焦虑、主观健康、治疗期望和治疗可接受性在各测量点的变化。
- 采用基于意向性治疗原则的多层线性混合模型检验CBT-I干预的疗效。
临床怎么用
- proACT-S作为自助失眠认知行为疗法,可能为重性抑郁共病失眠患者提供可及性高的早期干预选项。
- 若试验证实有效,该自助治疗可考虑融入社区精神卫生服务,减少面诊障碍。
局限性
- 本文件为研究方案,尚未报告疗效数据。
- 试验为回顾性注册(ClinicalTrials.gov NCT04228146,2020年1月14日注册)。
- 目标人群限于非自杀性、年龄大于17岁的香港华人,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Depression is a major public health concern. Emerging research has shown that cognitive behavioral therapy for insomnia (CBT-I) is effective in treating individuals with comorbid insomnia and depression. Traditional face-to-face CBT-I encounters many obstacles related to feasibility, accessibility, and help-seeking stigma. CBT-I delivered via smartphone application could be a potential solution. This paper reports a protocol designed to evaluate the efficacy of a self-help smartphone-based CBT-I, using a waitlist group as control, for people with major depression and insomnia. METHODS: A two-arm parallel randomized controlled trial is conducted in a target sample of 285 non-suicidal Hong Kong Chinese older than 17 years of age with major depression and insomnia. Participants complete an online rapid screening, followed by a telephone diagnostic interview. Those who meet the eligibility criteria are randomized in a ratio of 1:1 to receive either CBT-I immediately or to a waitlist control condition. The CBT-I consists of six weekly modules and is delivered through a smartphone application proACT-S. This smartphone app has been pilot tested and revamped to improve user experience. An online randomized algorithm is used to perform randomization to ensure allocation concealment. The primary outcomes are changes over the measurement points in sleep quality, insomnia severity, and depression severity. The secondary outcomes include changes over the measurement points in anxiety, subjective health, treatment expectancy, and acceptability of treatment. Assessments are administered at baseline, post-intervention, and 6-week follow-up. The recruitment is completed. Important adverse events, if any, are documented. Multilevel linear mixed model based on intention-to-treat principle will be conducted to examine the efficacy of the CBT-I intervention. DISCUSSION: It is expected that proACT-S is an efficacious brief sleep-focused self-help treatment for people with major depression and insomnia. If proven efficacious, due to its self-help nature, proACT-S may be applicable as a community-based early intervention, thereby reducing the burden of the public healthcare system in Hong Kong. TRIAL REGISTRATION: ClinicalTrials.gov NCT04228146 . Retrospectively registered on 14 January 2020.
引用
- Hui VK, Wong CY, Ma EK, et al. Treating depression with a smartphone-delivered self-help cognitive behavioral therapy for insomnia: study protocol for a parallel group randomized controlled trial. Trials. 2020. PMID: 33036655. doi:10.1186/s13063-020-04778-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。